Hanlin Gao - Jun 2, 2025 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Jun 2, 2025
Transactions value $
-$15,299
Form type
4
Date filed
6/3/2025, 04:47 PM
Previous filing
May 28, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gao Hanlin Chief Scientific Officer C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE /s/ Paul Kim as Attorney-in-Fact 2025-06-03 0001684532

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.
F2 The shares were sold in multiple transactions at prices ranging from $20.01 to $20.70, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.